【FINTEC 0150 交流专区】（前名 ASIABIO）

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	ESOS
Details of corporate proposal	Share Issuance Scheme
No. of shares issued under this corporate proposal	40,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0500
Par Value ($$)	Malaysian Ringgit (MYR)   0.000
Latest issued and paid up share capital after the above corporate proposal in the following
Units	1,113,382,600
Currency	Malaysian Ringgit (MYR) 0.000
Listing Date	31 Mar 2017

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- ACQUISITION OF SHARES IN FOCUS DYNAMICS GROUP BERHAD
Please refer to the attachment below.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5394801

Attachments ABT - Chapter 10 (Investment in Focus) - 12.04.2017.pdf

Tony-Pua

亚洲生物能源3股并1股
http://www.sinchew.com.my/node/1634661/

（吉隆坡17日讯）亚洲生物能源（ASIABIO，0150，创业板贸服组）拟落实并股计划，将3股并为1股，以减低市场流通股票数量，以及降低股价和市值波动。

该公司发文告表示，并股后股价和凭单价格料从6仙和3仙，分别增至18仙和9仙，同时有望提升每股盈利和净资产值表现。

排除任何不可预知因素，整个并股计划将在今年第二季完成。

文章来源：
星洲日报‧财经‧2017.04.18

Type	Announcement
Subject	SUBDIVISION / CONSOLIDATION OF SHARES (CHAPTER 13 OF LISTING REQUIREMENTS)
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR THE "COMPANY")PROPOSED SHARE CONSOLIDATION
On behalf of the Board of Directors of ABT, Mercury Securities Sdn Bhd wishes to announce that the Company proposes to undertake a proposed consolidation of every 3 ordinary shares in ABT (“ABT Shares” or “Shares”) into 1 ABT Share (“Proposed Share Consolidation”). Further details on the Proposed Share Consolidation are set out in the attachment below. This announcement is dated 17 April 2017.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5398101

Attachments ABT - Proposed Share Consolidation.pdf

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- ACQUISITION OF WARRANTS IN NETX HOLDINGS BERHAD
Please refer to the attachment below.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5415313

Attachments ABT - Chapter 10 (Investment in Netx Warrrants)(final) - 28.04.2017.pdf

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	ESOS
Details of corporate proposal	Share Issuance Scheme
No. of shares issued under this corporate proposal	43,000,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0500
Par Value ($$)	Malaysian Ringgit (MYR)   0.000
Latest issued and paid up share capital after the above corporate proposal in the following
Units	1,156,382,600
Currency	Malaysian Ringgit (MYR) 0.000
Listing Date	08 May 2017

哭哭鸟

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2017	31 Mar 2016	31 Mar 2017	31 Mar 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,879	2,943	5,354	9,518
2	Profit/(loss) before tax	15,941	-10,415	2,122	-28,828
3	Profit/(loss) for the period	15,941	-10,415	2,122	-28,828
4	Profit/(loss) attributable to ordinary equity holders of the parent	15,947	-9,272	2,146	-27,432
5	Basic earnings/(loss) per share (Subunit)	1.62	-1.07	0.22	-3.17
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.0476		0.0461

Tony-Pua

EX-date	01 Jun 2017
Entitlement date	05 Jun 2017
Entitlement time	05:00 PM
Entitlement subject	Share Consolidation
Entitlement description	BOOKS CLOSURE DATE FOR THE CONSOLIDATION OF EVERY 3 ORDINARY SHARES IN ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR THE "COMPANY") ("SHARES") INTO 1 SHARE ("CONSOLIDATED SHARE") AT 5.00 P.M. ON 5 JUNE 2017 ("SHARE CONSOLIDATION") ("BOOKS CLOSURE DATE")
Period of interest payment	to
Financial Year End	31 Mar 2018
Share transfer book & register of members will be	to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no	TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHDUnit 32-01, Level 32, Tower A,Vertical Business Suite, Avenue 3, Bangsar South,No. 8, Jalan Kerinchi59200 Kuala LumpurTel:03-27839299Fax:03-27839222
Payment date
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	05 Jun 2017
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Ratio
Ratio	3 : 1
Rights Issue/Offer Price
Par Value (if applicable)

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ('ABT" or "the Company")- PROPOSED ACQUISITION OF SHARES IN GOODWILL SELECTED SDN. BHD. ("GSSB") AND MATRIX CONCORD SDN. BHD. ("MCSB")
The Board of Directors of ABT wishes to announce that the Company and its wholly-owned subsidiary, Asiabio Petroleum Sdn. Bhd. (1112819-D) (“APSB”) had on 1 June 2017 acquired one (1) ordinary share representing 100% of the share capital of the following companies for a total cash consideration of RM2.00 (Ringgit Malaysia Two) only (RM1.00 each company) (collectively known as "Proposed Acquisitions”):- (a) GSSB GSSB was incorporated on 2 May 2017 pursuant to the Companies Act, 2016 as a private limited company and has not commenced business since its incorporation. The issued and paid-up capital of GSSB is RM1.00 with one (1) ordinary share. (b) MCSB MCSB was incorporated on 2 May 2017 pursuant to the Companies Act, 2016 as a private limited company and has not commenced business since its incorporation. The issued and paid-up capital of MCSB is RM1.00 with one (1) ordinary share. Subsequent to the Proposed Acquisitions: i.    GSSB shall become a wholly-owned subsidiary of ABT; and ii.   MCSB shall become a wholly-owned subsidiary of APSB, which in turn is a wholly-owned subsidiary of ABT. The Proposed Acquisitions would not have material effect on ABT Group’s earnings per share, net assets per share, gearing, share capital and substantial shareholders’ shareholding for the financial year ending 31 March 2018. None of the Directors and/or major shareholders of the Company and/or persons connected with them have any interest, direct or indirect, in the Proposed Acquisitions. Having considered all aspects of the Proposed Acquisitions, the Board of Directors of ABT is of the opinion that the Proposed Acquisitions are in the best interest of ABT. This announcement is dated 1 June 2017.

icy97

與中港企業合作 AsiaBio資本生產出口清真食品

2017年6月05日
（八打靈再也5日訊）馬中合作再添一筆，亞洲生物能源（ASIABIO，0150，創業板貿服）宣布，旗下子公司AsiaBio資本私人有限公司上週六（3日）與3家香港及中國企業簽署諒解備忘錄，合作生產及出口清真食品至全球市場。

據亞洲生物能源發布文告，上述3家企業分別是香港雨潤子辰國際集團（YRZC）、陝西紅彙食品有限責任公司（SXHHF）及山東王家園子清真食品釀造有限公司（SDWJYZHFB）。

NETX控股供電子服務

文告指出，在簽署上述備忘錄后，所有參與方將會根據中國文化和伊斯蘭教義即時展開新產品的研發，以創造一個值得信賴及擁有符合清真認證的品牌。

AsiaBio資本也將聯合YRZC代表所有上述參與方向大馬伊斯蘭發展局（JAKIM）申請清真認證執照，以出口旗下產品至全球市場。

上述備忘錄是在上週六于中國陝西省渭南市的2017年絲綢之路國際博覽會及第21屆中西合作投資與貿易論壇上所簽署。

NETX控股（NETX，0020，創業板科技）則會為上述電子商務市場提供電子支付服務。【中国报财经】

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- MEMORANDUM OF UNDERSTANDING BETWEEN ASIABIO CAPITAL SDN. BHD., A WHOLLY-OWNED SUBSIDIARY OF ABT, HONG KONG YRZC INTERNATIONAL GROUP CO, LTD, SHAN XI HONG HUI FOOD LIMITED LIABILITY COMPANY AND SHAN DONG WANG JIA YUAN ZI HALAL FOOD BREWING CO, LTD
Please refer to the attachment below.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5451857

Attachments ABT - Memorandum of Understanding entered into by ABC - 05.06.2017.pdf

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	ESOS
Details of corporate proposal	Share Issuance Scheme
No. of shares issued under this corporate proposal	27,665,500
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.1650
Par Value($$) (if applicable)	Malaysian Ringgit (MYR)   0.000
Latest issued share capital after the above corporate proposal in the following
Units	413,124,775
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 62,383,937.500
Listing Date	09 Jun 2017

icy97

亚洲生化获2.2亿合约

2017年6月9日
（吉隆坡8日讯）亚洲生化（ASIABIO，0150，创业板）获Tenisha 建筑有限公司颁发总值2亿2000万令吉的合约。

亚洲生化今日向交易所报备，独资子公司Asiabio石油昨日接到来自Tenisha 建筑的得标书（LOA）。

根据文告，上述合约，主要是负责位于柔佛边佳兰，脚手架和模板系统的设计、建造、审查、维持及拆卸。

Tenisha 建筑是国家石油（Petronas）认证服务供应商；它主要是为油气领域，提供工程及建筑综合专业服务。

预计Asiabio石油及Tenisha 建筑，将从获得标书日期算起，一个月内，执行分包协议。

亚洲生化指出，合约为期30个月，预计合约价值为2亿2000万令吉；相信将对亚洲生化贡献盈利。

Asiabio石油炼油与石油化工综合发展（RAPID）项目经理余松建说：“我们很高兴，因为这合约对公司来说是一大迈进；作为国油RAPID大型项目的一部分，相信公司能从边佳兰石油综合中心（PIPC）的长期商机中获益。”

他补充，该公司将专注在工程与维修工作，而该些服务将是油气领域上游及下游业务所需。【e南洋】

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- LETTER OF AWARD ("LOA") BY TENISHA CONSTRUCTION SDN. BHD. TO ASIABIO PETROLEUM SDN. BHD. IN RELATION TO THE CONTRACT FOR THE  UTILITIES, INTERCONNECTING OFFICE SITE (UIO) FACILITIES: DESIGN, ERECT, INSPECT, MAINTAIN AND DISMANTLE OF SCAFFOLDING SYSTEMS, PACKAGE 14-SS16C (CONTRACT NO: PC14-C- K-0001- SS16C)
The Board of Directors of ABT is pleased to announce that its wholly-owned subsidiary company, Asiabio Petroleum Sdn. Bhd. (“ABP” or “Subcontractor”) has on 7 June 2017 received a letter of award (“LOA”) from Tenisha Construction Sdn. Bhd. (“Tenisha” or “Site Services Contractor”) for the subcontracting work involving the design, erect, inspect, maintain and dismantle of scaffolding systems for the Utilities, Interconnecting, Officesite (UIO) Facilities (CONTRACT NO: PC14-C- K-0001- SS16C). Tenisha, incorporated on 2 December 2014, is a Petronas-accredited service provider based in Johor that specializes in providing multi-disciplinary engineering and construction services in the oil & gas industry. The company had commenced operations in the oil and gas industry in May 2016 and has since been successful in securing various work orders from PRPC Utilities and Facilities Sdn. Bhd., the owner of the contract in relation to Petroliam Nasional Berhad’s (PETRONAS) proposed Refinery and Petrochemical Integrated Development (RAPID) complex in Pengerang, Johor, which is a mega-project within the Pengerang Integrated Petroleum Complex (PIPC). ABP and Tenisha is expected to execute a Subcontract Agreement within one (1) month from the date of the LOA, upon which an announcement will be made. The contract value is expected to be on a unit rate basis as set in the LOA for works carrying RM220 million in total estimated value over a thirty months (30) period. Tenisha will be responsible for the payment to ABP for any subscontracting work carried out in accordance to the terms of the Subcontracting Agreement to be signed between the parties. The LOA will not have any effect on the share capital, earnings and net assets of the Company for financial year ending 31 March 2018, however, it is expected to contribute positively to the future earnings of the ABT Group. None of the Directors and/or major shareholders of ABT and/or persons connected with them have any interests, direct or indirect, in the LOA. This announcement is dated 8 June 2017.

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- PROPOSED ACQUISITION OF SHARES IN PERFECT POWER GROUP LIMITED
The Board of Directors of ABT wishes to announce that the Company had on 16 June 2017 acquired one hundred (100) ordinary shares of USD1.00 each, representing 100% of the share capital of Perfect Power Group Limited (Company No. 1946247) (“PPGL”) for a total cash consideration of USD100.00 (US Dollar One Hundred), equivalent to RM427.85 (Ringgit Malaysia Four Hundred Twenty Seven and Sen Eighty Five) only (Proposed Acquisition”). PPGL is dormant and was incorporated on 26 May 2017 pursuant to the BVI Business Companies Act, 2004 as a company limited by shares. The authorised share capital of the Company is USD50,000.00 of 50,000 ordinary shares of USD1.00 each. The issued and paid-up capital of PPGL is USD100.00 (US Dollar One Hundred) of 100 ordinary shares of USD1.00 each. Subsequent to the Proposed Acquisition, PPGL shall become a wholly-owned subsidiary of ABT. The Proposed Acquisition would not have any material effects on ABT Group’s earnings per share, net assets per share, gearing, share capital and substantial shareholders’ shareholding for the financial year ending 31 March 2018. None of the Directors and/or major shareholders of the Company and/or persons connected with them have any interest, direct or indirect, in the Proposed Acquisition. Having considered all aspects of the Proposed Acquisition, the Board of Directors of ABT is of the opinion that the Proposed Acquisition is in the best interest of ABT. This announcement is dated 16 June 2017.

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	ESOS
Details of corporate proposal	Share Issuance Scheme
No. of shares issued under this corporate proposal	28,600,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.1400
Par Value($$) (if applicable)	Malaysian Ringgit (MYR)   0.000
Latest issued share capital after the above corporate proposal in the following
Units	441,724,775
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 66,387,937.500
Listing Date	13 Jul 2017

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- SUBSCRIPTION OF PRIVATE PLACEMENT SHARES OF DGB ASIA BERHAD ("DGB") PURSUANT TO RULE 9.19(26) OF THE ACE MARKET LISTING REQUIREMENTS
Please refer to the attachment below.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5486037

Attachments ABT - Chapter 9.19(26) (Subscription of Private Placement Shares of DGB) - 13.07.2017.pdf

icy97

亚洲生物能源增持T7全球2.03%

（吉隆坡14日讯）亚洲生物能源（ASIABIO,0150,创业板贸服组）透过公开市场频频吸纳T7全球（T7GLOBAL,7228,主板贸服组）775万股或2.03%股权，共耗资2805万945令吉57仙。

亚洲生物能源发文告表示，收购T7全球股权，主要是充作投资用途，因T7全球业务与亚洲生物能源旗下的石油业务相似。亚洲能源是在2016年10月19至2017年7月13日吸纳上述股权。

彭博社资料显示，T7全球核心业务为石油领域提供维修设备、项目管理、建筑等服务。

文章来源：
星洲日报／财经‧2017.07.15

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- ACQUISITION OF SHARES IN T7 GLOBAL BERHAD
Please refer to the attachment below.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5487125

Attachments ABT - Chapter 10 (Acquisition of shares in T7 Global Berhad) - 14.07.2017.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- SUBSCRIPTION OF PRIVATE PLACEMENT SHARES OF DGB ASIA BERHAD ("DGB") PURSUANT TO RULE 9.19(26) OF THE ACE MARKET LISTING REQUIREMENTS
Further to the Company’s announcement dated 13 July 2017, the Board of Directors of the Company wishes to clarify that item 2.3 - Basis of Arriving At the Consideration, should be read as follows:- “The Consideration was determined after fixing the issue price of RM0.03762 per Placement Share on 6 July 2017 which is calculated based on a representation of 10% discount of 10.0% to the 5-day Volume Weighted Average Price of DGB Shares of RM0.0418 which amounts to a total consideration of RM1,839,618.00.” This announcement is dated 14 July 2017.

icy97

ASIA BIOENERGY TECHNOLOGIES BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	ESOS
Details of corporate proposal	Share Issuance Scheme
No. of shares issued under this corporate proposal	8,584,000
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.1250
Par Value($$) (if applicable)	Malaysian Ringgit (MYR)   0.000
Latest issued share capital after the above corporate proposal in the following
Units	450,308,775
Issued Share Capital ($$)	Malaysian Ringgit (MYR) 69,787,111.100
Listing Date	04 Aug 2017

icy97

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR THE "COMPANY")(I)        PROPOSED RIGHTS ISSUE OF ICPS WITH WARRANTS; (II)        PROPOSED CONSTITUTION AMENDMENTS; AND(III)        PROPOSED BYLAWS AMENDMENTS(COLLECTIVELY REFERRED TO AS THE "PROPOSALS")
On behalf of the Board of Directors of ABT, Mercury Securities Sdn Bhd wishes to announce that the Company proposes to undertake the following:- (i)         proposed renounceable rights issue of up to 1,163,208,800 new irredeemable convertible preference shares in ABT (“ICPS”) together with up to 116,320,880 free detachable warrants in ABT (“Warrants B”) on the basis of 10 ICPS together with 1 free Warrant B for every 5 existing ordinary shares in ABT (“ABT Shares” or “Shares”) held by the entitled shareholders on an entitlement date to be determined (“Proposed Rights Issue of ICPS with Warrants”); (ii)         proposed amendments to the Constitution / Memorandum and Articles of Association of the Company (“Proposed Constitution Amendments”); and (iii)        proposed amendments to the bylaws governing the existing share issuance scheme of ABT (“Proposed Bylaws Amendments”) (collectively referred to as the “Proposals”). Please refer to the attached document for further details on the Proposals. This announcement is dated 11 August 2017.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5513185

Attachments ABT - Proposals (11.8.2017).pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2017	30 Jun 2016	30 Jun 2017	30 Jun 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	1,909	1,507	1,909	1,507
2	Profit/(loss) before tax	39,073	-7,689	39,073	-7,689
3	Profit/(loss) for the period	39,073	-7,689	39,073	-7,689
4	Profit/(loss) attributable to ordinary equity holders of the parent	39,088	-7,683	39,088	-7,683
5	Basic earnings/(loss) per share (Subunit)	10.09	-0.86	10.09	-0.86
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2422		0.0476

icy97

亚洲生化1127万入股MLABS

2017年9月16日
（吉隆坡15日讯）亚洲生化（ASIABIO，0150，创业板）宣布以1126万5000令吉，收购MLABS系统（MLAB，0085，创业板）的7510万股，相等于13.16%股权。

亚洲生化向交易所报备，收购价相等于每股15仙，是理论除权价的约8.37%折价。

亚洲生化表示，收购MLABS系统符合公司攫取增长前景佳的上市公司的策略。

该公司乐观看待，上述收购可在近期内提供回酬，因为MLABS系统计划发展及营销一款手机应用程式。

这款应用程式，可让数名用户一起参与语音和视频会议。同时，也能传送文字和语音通话。【e南洋】

Type	Announcement
Subject	OTHERS
Description	ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- SUBSCRIPTION OF RIGHTS AND EXCESS SHARES OF MLABS SYSTEMS BERHAD ("MLABS") PURSUANT TO RULE 9.19(26) AND RULE 10.06 OF THE ACE MARKET LISTING REQUIREMENTS
The Board of Directors of Asia Bioenergy Technologies Berhad (“ABT” or “the Company”) wishes to announce that its wholly-owned subsidiary, Asiabio Capital Sdn. Bhd. has on 15 September 2017 acquired 75,100,000 shares of Mlabs Systems Berhad (“MLABS”), representing 13.16% equity interest in MLABS, via the subscription of the rights and excess shares of MLABS at an issue price of RM0.15 each (“Shares”) for a total cash consideration of RM11,265,000 (“Consideration”). Pursuant to the acquisition, Asiabio Capital Sdn. Bhd. will also be issued 37,550,000 free Warrants B of MLABS. Please refer to the attachment below for more details.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/5545765

Attachments ABT - Chapter 9.19(26) (Subscription of Right and Excess Shares of Mlabs)(Final) - 15.09.2017.pdf